Form DEFA14A Lyell Immunopharma, Inc.
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. )
|
Filed by the Registrant
|
☒ | |
|
|
Filed by a Party other than the Registrant
|
☐ | |
Check the appropriate box:
|
☐
|
| |
Preliminary Proxy Statement
|
|
☐
|
| |
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
|
☐
|
| |
Definitive Proxy Statement
|
|
☒
|
| |
Definitive Additional Materials
|
|
☐
|
| |
Soliciting Material Pursuant to § 240.14a-12
|
|
LYELL IMMUNOPHARMA, INC.
|
|
(Name of Registrant as Specified In Its Charter)
|
|
|
|
(Name of Person(s) Filing Proxy Statement if other than the Registrant)
|
Payment of Filing
Fee (Check all boxes that apply):
|
☒
|
| |
No fee required
|
|
☐
|
| |
Fee paid previously with preliminary materials
|
|
☐
|
| |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Provation Expands Global Footprint with Launch of Provation® Apex in Australia and New Zealand
- Bueno Plumbing and Rooter Announces Expanded California Plumbing Services Across Northern and Southern California
- Christina Bedal Announces Release of The Shark Effect, A New Framework for Understanding Workplace Instincts
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
